Margaret Kaczor
Stock Analyst at William Blair
(0)
# 5037
Out of 5,218 analysts
35
Total ratings
30.77%
Success rate
-43.40%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CeriBell | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Nov 5, 2024 | |
Neuronetics | Downgrades: Market Perform | n/a | n/a | n/a | 4 | Aug 12, 2024 | |
CVRx | Downgrades: Market Perform | n/a | n/a | n/a | 2 | May 1, 2024 | |
Cutera | Upgrades: Market Perform | n/a | n/a | n/a | 3 | Mar 22, 2024 | |
Inogen | Upgrades: Outperform | n/a | n/a | n/a | 4 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 5 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Sep 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Mar 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Sep 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Market Perform | n/a | n/a | n/a | 1 | Jun 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 2 | Jan 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Apr 27, 2017 |